Big Pharma’s Pandemic Profiteering Isn’t Over
Pharma giant Pfizer expects to make more than $50 billion from its Covid medicines this year, and it isn’t a one-off – it’s a symbol of the drastic inequality resulting from a monopolistic approach to global health.